OR WAIT null SECS
August 08, 2023
Lower levels of an active ingredient may result in unexpected pregnancies.
August 03, 2023
The nasal-spray drug can be used to reverse the effects of opioid overdose.
August 02, 2023
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
August 01, 2023
The program aims to aid submissions from external stakeholders and FDA staff.
The guidance document outlines recommendations to limit potential carcinogenic risk.
July 28, 2023
Pandemic, PBM, and other policies on hold during the summer recess.
July 27, 2023
Tarsus Pharmaceuticals’ Xdemvy (lotilaner ophthalmic solutions) is designed to treat Demodex blepharitis by directly targeting Demodex mites.
July 25, 2023
The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.
July 24, 2023
The framework is now expanded beyond COVID-19 vaccines and treatments.